Covid-19 and CVD clinical resources

A collection of resources on Covid-19 and cardiovascular disease for health professionals and related information for patients.

Clinical resources

Guidance on myocarditis and pericarditis after mRNA COVID-19 Vaccines

The Australian Technical Advisory Group on Immunisation (ATAGI) and the Cardiac Society of Australia and New Zealand (CSANZ) has issued the following updated guidance on myocarditis and pericarditis after Covid 19 vaccinations. Updated November 2022.

Read the advice (PDF)

Cardiovascular disease and Covid-19: Australian and New Zealand consensus statement – April 2020

A consensus statement summarising current available data on Covid-19 and cardiovascular disease has been published in the Medical Journal of Australia. 

The statement highlights issues of Covid-19 complications in cardiac patients and advises health services on ways they can minimise transmission risk while continuing to deliver cardiac care. It is a ‘living document’ and will be updated as more information becomes available.

The statement is endorsed by:

  • Cardiac Society of Australia and New Zealand (CSANZ)
  • The Heart Foundation of Australia
  • High Blood Pressure Research Council of Australia
  • Australian and New Zealand Society of Cardiac and Thoracic Surgeons

Read the consensus statement

Other useful links

Resources for patients

Online Covid-19 information

We also have a number of information pages for cardiac patients about Covid-19. These will be updated in coming weeks.

Other quick links